Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Alpine Immune Sciences Inc (NASDAQ: ALPN) closed at $64.58 in the last session, up 0.05% from day before closing price of $64.55. In other words, the price has increased by $0.05 from its previous closing price. On the day, 1.79 million shares were traded. ALPN stock price reached its highest trading level at $64.58 during the session, while it also had its lowest trading level at $64.445.
Ratios:
We take a closer look at ALPN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.86 and its Current Ratio is at 7.86. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on April 09, 2024, initiated with a Buy rating and assigned the stock a target price of $55.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $44.
On October 18, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $18.Berenberg initiated its Buy rating on October 18, 2023, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 26 ’24 when Rickey James Paul sold 117,764 shares for $23.32 per share. The transaction valued at 2,745,830 led to the insider holds 0 shares of the business.
Rickey James Paul sold 236 shares of ALPN for $5,192 on Jan 25 ’24. The insider now owns 0 shares after completing the transaction at $22.00 per share. On Dec 28 ’23, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, sold 1,364,849 shares for $18.35 each. As a result, the insider received 25,049,034 and left with 264,315 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALPN now has a Market Capitalization of 4233897216 and an Enterprise Value of 3913505024. For the stock, the TTM Price-to-Sale (P/S) ratio is 71.90 while its Price-to-Book (P/B) ratio in mrq is 11.88. Its current Enterprise Value per Revenue stands at 66.47 whereas that against EBITDA is -89.607.
Stock Price History:
Over the past 52 weeks, ALPN has reached a high of $64.57, while it has fallen to a 52-week low of $6.71. The 50-Day Moving Average of the stock is 62.16%, while the 200-Day Moving Average is calculated to be 208.03%.
Shares Statistics:
According to the various share statistics, ALPN traded on average about 2.20M shares per day over the past 3-months and 6951080 shares per day over the past 10 days. A total of 60.35M shares are outstanding, with a floating share count of 47.05M. Insiders hold about 28.22% of the company’s shares, while institutions hold 68.42% stake in the company. Shares short for ALPN as of 1711584000 were 5284601 with a Short Ratio of 2.40, compared to 1709164800 on 4427533. Therefore, it implies a Short% of Shares Outstanding of 5284601 and a Short% of Float of 13.139999999999999.
Earnings Estimates
A detailed examination of Alpine Immune Sciences Inc (ALPN) is currently in progress, with Align Technology, Inc. analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $4.75, with high estimates of $0.75 and low estimates of $35.12.
